Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer.

@article{Lorenz1998IsolatedHP,
  title={Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer.},
  author={Matthias W. Lorenz and Henrik Petrowsky and Stefan S. Heinrich and G. P. Janshon and Elsbeth Staib-Sebler and Y Poloczek and Christiane Gog and Gerhard Maximilian Oremek and Albrecht Encke},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={1998},
  volume={24 6},
  pages={
          542-7
        }
}
AIMS Chemotherapy as a palliative therapy option for patients with advanced pancreatic cancer remains disappointing. Some authors have recently claimed high response rates and a prolongation of median survival after regional chemotherapy. Isolated perfusion may result in the highest drug concentrations within the target tissue without causing systemic side-effects. An established, commercially available system of isolated hypoxic perfusion (IHP) was therefore evaluated in patients with… CONTINUE READING
6 Citations
0 References
Similar Papers